Hypothalamic Obesity: The Sixth Cranial Endocrinopathy
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The hypothalamus is “ground zero” for the neuroendocrine control of five hormonal systems, which are mediated through negative feedback regulation of pituitary hormone release. Energy balance is regulated by a more complex neuroendocrine feedback loop. The hypothalamus integrates peripheral neural and hormonal afferent signals of satiety and energy reserve and directs neuroendocrine efferent arms to effect energy storage versus expenditure; however, in this feedback loop, the pituitary is not integral. Damage to this hypothalamic control system results in a syndrome of intractable weight gain. This syndrome of hypothalamic obesity is usually caused by cranial insult, such as brain trauma, tumor, surgery, or radiation. In some cases, however, it may have a congenital cause. The cause and pathogenesis of obesity in such subjects is akin to an animal model of obesity in which the ventromedial hypothalamus (VMH) is destroyed or deafferented. The VMH-lesioned rat exhibits a vagally mediated potentiation of insulin secretion in response to glucose. Excess insulin secretion favors and promotes partitioning of energy substrate into fat, even with caloric restriction. Similarly, patients with hypothalamic obesity exhibit insulin hypersecretion. By suppressing insulin release at the β cell in a specific manner using the somatostatin agonist octreotide, the shunting of energy substrate to adipose is attenuated. Treated patients exhibit weight loss and improved quality of life, which correlate with insulin suppression. Thus, hypothalamic obesity is the sixth cranial endocrinopathy, with an identifiable cause, pathogenesis, diagnosis, and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Kalra, S. P. (1999) · Endocrine Reviews · doi:10.1210/er.20.1.68 · Cited by 1,554
Elmquist, J. K., Elias, C. F., & Saper, C. B. (1999) · Neuron · doi:10.1016/s0896-6273(00)81084-3 · Cited by 1,160
Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis
Bray, G. A., & York, D. A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.719 · Cited by 1,132
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., & Froguel, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9238 · Cited by 897
Ahrén, B., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1030 · Cited by 292
BERTHOUD, H. R., & JEANRENAUD, B. (1979) · Endocrinology · doi:10.1210/endo-105-1-146 · Cited by 266
THE GROWTH WITHOUT GROWTH HORMONE SYNDROME
Geffner, M. E. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70345-5 · Cited by 108
Rohner-Jeanrenaud, F., & Jeanrenaud, B. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109744 · Cited by 80
Cited by
August, G. P., Caprio, S., Fennoy, I., Freemark, M., Kaufman, F. R., Lustig, R. H., Silverstein, J. H., Speiser, P. W., Styne, D. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2458 · Cited by 524
Self-citationRisk Factors for the Development of Obesity in Children Surviving Brain Tumors
Lustig, R. H., Post, S. R., Srivannaboon, K., Rose, S. R., Danish, R. K., Burghen, G. A., Xiong, X., Wu, S., & Merchant, T. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021180 · Cited by 305
Self-citationOctreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial
Lustig, R. H., Hinds, P. S., Ringwald-Smith, K., Christensen, R. K., Kaste, S. C., Schreiber, R. E., Rai, S. N., Lensing, S. Y., Wu, S., & Xiong, X. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030003 · Cited by 299
Self-citationMüller, H. L., Emser, A., Faldum, A., Bruhnken, G., Etavard-Gorris, N., Gebhardt, U., Oeverink, R., Kolb, R., & Sörensen, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031751 · Cited by 287
Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity
Seifarth, C., Schehler, B., & Schneider, H. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1327734 · Cited by 258
Metadata
- Authors
- Lustig, R. H.
- Venue
- The Endocrinologist
- Published
- 2002-05
- Volume
- 12
- Issue
- 3
- Pages
- 210-217
- ISSN
- 1051-2144 (ISSN-L)
- OpenAlex
- W2322634847
- Cited by
- 82
- References
- 9
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypothalamic Obesity: The Sixth Cranial Endocrinopathy. https://app.cochat.ai/papers/10.1097/00019616-200205000-00008
- The paper
- Lustig, R. H. (2002). Hypothalamic Obesity: The Sixth Cranial Endocrinopathy. The Endocrinologist. https://doi.org/10.1097/00019616-200205000-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.